World's Best Scientists 2026 revealed!
Award Badge
Immunology
UK
2026
Award Badge
Medicine
UK
2026

D-Index & Metrics

Immunology

D-Index
157
Citations
95289
World Ranking
94
National Ranking
7

Medicine

D-Index
158
Citations
95809
World Ranking
850
National Ranking
90

Research.com Recognitions

  • 2026 - Research.com Immunology in United Kingdom Leader Award
  • 2026 - Research.com Medicine in United Kingdom Leader Award
  • 2025 - Research.com Immunology in United Kingdom Leader Award
  • 2025 - Research.com Medicine in United Kingdom Leader Award
  • 2023 - Research.com Medicine in United Kingdom Leader Award
  • 2022 - Research.com Immunology in United Kingdom Leader Award

Overview

Adrian V. S. Hill is affiliated with the University of Oxford in the United Kingdom. Their research predominantly focuses on the fields of Medicine and Immunology and Microbiology. Within these fields, their work extends into several specialized subfields, including Infectious Diseases, Public Health, Environmental and Occupational Health, Immunology, Molecular Biology, and Epidemiology.

Their main research topics cover a range of areas related to infectious disease control and immune response mechanisms. These topics include Malaria Research and Control, SARS-CoV-2 and COVID-19 Research, Mosquito-borne Diseases and Control, Vaccines and Immunoinformatics Approaches, COVID-19 Clinical Research Studies, Immunotherapy and Immune Responses, and Viral Infections and Outbreaks Research.

The scientist has contributed to numerous research publications, frequently collaborating with several co-authors. Notable frequent co-authors include Katie Ewer, Alexander J. Mentzer, Sarah C. Gilbert, Andrew J. Pollard, and Pedro M. Folegatti.

Adrian V. S. Hill has published extensively in several scientific venues. The most frequent venues are bioRxiv (Cold Spring Harbor Laboratory), Zenodo (CERN European Organization for Nuclear Research), Frontiers in Immunology, SSRN Electronic Journal, and The Lancet.

Significant recent papers include:

  • Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK, 2020, The Lancet
  • Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial, 2020, The Lancet
  • Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection, 2021, Nature Medicine
  • Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials, 2021, The Lancet
  • Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial, 2021, The Lancet

Best Publications

  • Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

    Paul R. Burton;David G. Clayton;Lon R. Cardon;Nick Craddock

  • Common West African HLA antigens are associated with protection from severe malaria

    Adrian V. S. Hill;Catherine E. M. Allsopp;Dominic Kwiatkowski;Nicholas M. Anstey

  • Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.

    William McGuire;Adrian V. S. Hill;Catherine E. M. Allsopp;Brian M. Greenwood

  • Genome-wide association study identifies eight loci associated with blood pressure

    Christopher Newton-Cheh;Christopher Newton-Cheh;Toby Johnson;Toby Johnson;Vesela Gateva;Martin D. Tobin

  • Erratum: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

    A D Douglas;A R Williams;J J Illingworth;G Kamuyu

  • Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants

    Paul R Burton;David G Clayton;Lon R Cardon;Nick Craddock

  • TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.

    D. Kwiatkowski;A. V. S. Hill;I. Sambou;P. Twumasi

  • Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans.

    Richard Bellamy;Cyril Ruwende;Tumani Corrah;Keith P.W.J. McAdam

  • Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls

    Nick Craddock;Matthew E. Hurles;Niall Cardin;Richard D. Pearson

  • Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

    Jörg Schneider;Sarah C. Gilbert;Tom J. Blanchard;Tomas Hanke

  • Rapid Effector Function in CD8+ Memory T Cells

    Ajit Lalvani;Roger Brookes;Sophie Hambleton;Warwick J. Britton

  • Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

    Pedro M Folegatti;Katie J Ewer;Parvinder K Aley;Brian Angus

  • Molecular analysis of the association of HLA-B53 and resistance to severe malaria.

    A V Hill;J Elvin;A C Willis;M Aidoo

  • THE IMMUNOGENETICS OF HUMAN INFECTIOUS DISEASES

    Adrian V. S. Hill

  • Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study

    Emma E Davenport;Katie L Burnham;Jayachandran Radhakrishnan;Peter Humburg

  • Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.

    Helen McShane;Ansar A Pathan;Clare R Sander;Sheila M Keating

  • Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells.

    Ajit Lalvani;Ansar A. Pathan;Helen McSHANE;Robert J. Wilkinson

  • Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.

    Samuel J McConkey;William H H Reece;Vasee S Moorthy;Daniel Webster

  • In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope.

    Robert P. Anderson;Pilar Degano;Andrew J. Godkin;Derek P. Jewell

  • Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A

    Sergey Nejentsev;Joanna M. M. Howson;Neil M. Walker;Jeffrey Szeszko

  • Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine (preprint)

    Voysey, Merryn, Costa Clemens, Sue Ann, Madhi, Shabir A.;Weckx, Lily Yin, Folegatti, Pedro M.;Parvinder K. Aley;Angus, Brian John, Baillie, Vicky, Barnabas, Shaun L.

Frequent Co-Authors

Sarah C. Gilbert
Sarah C. Gilbert University of Oxford
Katie J. Ewer
Katie J. Ewer University of Oxford
Simon J. Draper
Simon J. Draper University of Oxford
Helen McShane
Helen McShane University of Oxford
Philip Bejon
Philip Bejon University of Oxford
Ian D. Poulton
Ian D. Poulton University of Oxford
Dominic P. Kwiatkowski
Dominic P. Kwiatkowski University of Oxford
Alfredo Nicosia
Alfredo Nicosia University of Naples Federico II
Kevin Marsh
Kevin Marsh University of Oxford
Robert E. Sinden
Robert E. Sinden Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, related healthcare degrees offer diverse career paths that complement this field. Many quickly transition to advanced roles through accelerated NP programs online, which provide an efficient route to becoming a Nurse Practitioner with a strong foundation in patient immunological care.

Those without a nursing background can explore online ABSN programs for non nurses. These programs are designed to fast-track non-nursing students into the nursing profession, enabling them to gain critical clinical skills relevant to immunology and infection control.

Finding the right program is crucial, especially when considering prerequisites and admission difficulty. For example, students may look into the easiest ABSN program to get into to begin a career quickly while maintaining strong academic support.

Moreover, entry-level pathways like Licensed Practical Nurse programs are popular starting points. Individuals often seek out which LPN programs are easiest to get into to enter the healthcare workforce promptly, gaining valuable experience applicable in immunology-related settings.

Best Scientists Citing Adrian V. S. Hill

Trending Scientists

Recently Published Articles